Compile Data Set for Download or QSAR
Report error Found 124 Enz. Inhib. hit(s) with all data for entry = 11576
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM50450959(CHEMBL4210698 | US11795171, Compound I-56)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628372(3-((1-(3-(1H-pyrrol-1-yl)butanoyl)-4-hydroxypiperi...)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628316(3-((4-Hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl)m...)
Affinity DataIC50: 250nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628396((R)-N-(3-((4-hydroxy-1-(3-phenylbutanoyl)piperidin...)
Affinity DataIC50: 250nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628397((R)-1-(3-((4-hydroxy-1-(3-phenylbutanoyl)piperidin...)
Affinity DataIC50: 250nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628391(3-((4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl)m...)
Affinity DataIC50: 250nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628340(3-((4-hydroxy-1-(3-(1-methyl-1H-indol-2-yl)benzoyl...)
Affinity DataIC50: 250nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628398(3-((4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl)m...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628399(3-((4-hydroxy-1-(2-methyl-3-phenylpropanoyl)piperi...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628336(3-((4-hydroxy-1-(3-(quinolin-6-yl)benzoyl)piperidi...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628394(3-((1-(3-chloro-4'-(piperidine-1-carbonyl)-[1,1'-b...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628331(3'-(4-hydroxy-4-((4-oxopyrrolo[2,1-f][1,2,4]triazi...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628344(3-((1-(2'-fluoro-[1,1'-biphenyl]-3-carbonyl)-4-hyd...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628345(3-((1-(3'-fluoro-[1,1'-biphenyl]-3-carbonyl)-4-hyd...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628338(3-((1-(3-(benzo[d]thiazol-5-yl)benzoyl)-4-hydroxyp...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628339(3-((4-hydroxy-1-(3-(5-methyl-1H-indazol-4-yl)benzo...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628382(3-((4-hydroxy-1-(4-((5-methyl-3-(trifluoromethyl)-...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628383(3-((1-(4-((1H-benzo[d][1,2,3]triazol-1-yl)methyl)b...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628320(3-((1-(3-(benzo[d][1,3]dioxol-5-yl)benzoyl)-4-hydr...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628384(3-((1-(4-((3,5-dimethyl-1H-pyrazol-1-yl)methyl)ben...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628321(3-((4-hydroxy-1-(2'-methyl-[1,1'-biphenyl]-3-carbo...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628385(3-((4-hydroxy-1-(4-(thiophen-2-ylmethyl)benzoyl)pi...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628378(3-((4-hydroxy-1-(2-methyl-3-phenylpropanoyl)piperi...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628379(3-((1-(4-((1H-benzo[d]imidazol-1-yl)methyl)benzoyl...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628380(3-((1-(4-((1H-pyrazol-1-yl)methyl)benzoyl)-4-hydro...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628326(3-((1-([1,1'-biphenyl]-3-carbonyl)-4-hydroxypiperi...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628327(3-((1-(4'-chloro-[1,1'-biphenyl]-3-carbonyl)-4-hyd...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628328(3-((1-(3'-chloro-[1,1'-biphenyl]-3-carbonyl)-4-hyd...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628392(3-((4-hydroxy-1-(2-methyl-3-phenylpropanoyl)piperi...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628322(3-((4-hydroxy-1-(4'-methyl-[1,1'-biphenyl]-3-carbo...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628386(3-((1-(4-benzoylbenzoyl)-4-hydroxypiperidin-4-yl)m...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628323(3-((4-Hydroxy-1-(4'-methoxy-[1,1'-biphenyl]-3-carb...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628387(3-((1-(4-(ethyl(phenyl)amino)benzoyl)-4-hydroxypip...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628366(3-((1-(3-chloro-4'-(pyrrolidine-1-carbonyl)-[1,1'-...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628431(3-((1-benzoyl-4-hydroxypiperidin-4-yl)methyl)-7-ph...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628368(3-((1-(2-benzyl-3,3-dimethylbutanoyl)-4-hydroxypip...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628428(N-(3-((1-(Cyclopropanecarbonyl)-4-hydroxypiperidin...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628364(6-chloro-3-((4-hydroxy-1-(3-phenylbutanoyl)piperid...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628430(N-(4'-(4-hydroxy-4-((4-oxopyrrolo[2,1-f][1,2,4]tri...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628307(US11795171, Compound I-119 | 3-([4-hydroxy-1-[3-(1...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 15 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628375(3-((1-(2-benzylbutanoyl)-4-hydroxypiperidin-4-yl)m...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628376(3-((4-hydroxy-1-(4-(phenylsulfonyl)benzoyl)piperid...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628311(3-((1-(2-cyclopropyloxazole-5-carbonyl)-4-hydroxyp...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 15 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628377(3-((4-hydroxy-1-(4-(phenylthio)benzoyl)piperidin-4...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628312(3-((1-(4-(1H-pyrazol-1-yl)benzoyl)-4-hydroxypiperi...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 15 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628370(3-((4-hydroxy-1-(4-(2-phenylpropan-2-yl)benzoyl)pi...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628306(3-((1-(4-fluorobenzoyl)-4-hydroxypiperidin-4-yl)me...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 15 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628307(US11795171, Compound I-119 | 3-([4-hydroxy-1-[3-(1...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 15 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628353(4'-(4-hydroxy-4-((4-oxopyrrolo[2,1-f][1,2,4]triazi...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Valo Health

US Patent
LigandPNGBDBM628358(3-((4-hydroxy-1-(4-(quinolin-6-yl)benzoyl)piperidi...)
Affinity DataIC50: 600nMAssay Description:Each assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning 46...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2023
Entry Details
US Patent

Displayed 1 to 50 (of 124 total ) | Next | Last >>
Jump to: